πŸ‡ΊπŸ‡Έ FDA
Patent

US 9598404

Deoxycytidine kinase inhibitors

granted A61KA61K31/426A61K31/44

Quick answer

US patent 9598404 (Deoxycytidine kinase inhibitors) held by The Regents of the University of California expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/426, A61K31/44, A61K31/506, A61K31/513